The Impact of SARS-CoV-2 Vaccine Dose Separation and Dose Targeting on Hospital Admissions and Deaths from COVID-19 in England

Matt J. Keeling, Samuel Moore, Bridget Penman, Edward M. Hill
doi: https://doi.org/10.1101/2022.08.22.22278973

Article Information

doi 
https://doi.org/10.1101/2022.08.22.22278973
History 
  • November 21, 2022.

Article Versions

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Matt J. Keeling1,2,*,
  2. Samuel Moore3,2,
  3. Bridget Penman1 and
  4. Edward M. Hill1,2
  1. 1The Zeeman Institute for Systems Biology & Infectious Disease Epidemiology Research, University of Warwick, Coventry, CV4 7AL, UK
  2. 2Joint UNIversities Pandemic and Epidemiological Research, https://maths.org/juniper/
  3. 3Lancaster Medical School, Lancaster University, Lancaster, LA1 4YW, UK
  1. ↵*Corresponding author; email: m.j.keeling{at}warwick.ac.uk
Back to top
Posted November 21, 2022.
Download PDF

Supplementary Material

Data/Code
Email
The Impact of SARS-CoV-2 Vaccine Dose Separation and Dose Targeting on Hospital Admissions and Deaths from COVID-19 in England
Matt J. Keeling, Samuel Moore, Bridget Penman, Edward M. Hill
medRxiv 2022.08.22.22278973; doi: https://doi.org/10.1101/2022.08.22.22278973
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area